Uganda has been hailed for combating HIV/AIDS epidemic from 18% prevalence in 1992 to 6.1% in 2000. However it has now risen to 6.4% in 2004/5. Northern Uganda which has faced political turmoil and insurgency for the past ...

The research was motivated by the low ARV demand response following the introduction of generic ARV drugs which lead to a cost reduction in Uganda’s adopted first line ARV treatment (AZT+D4T+NVP) from US$ 456 per month in ...

The main objective of the study was to examine the determinants of VCT (voluntary counseling and testing) uptake among the sexually active group (15-54 years) in Uganda. The study examined secondary data from the UDHS ...